INBS

1.30

2.36% 0.03

Dopo l'orario di chiusura: 1.37 0.07 +5.38%

Intelligent Bio Solutions Inc (INBS)

Panoramica Notizia Cronologia dei prezzi Financials Perché INBS Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.27

Aprire:

$1.27

Volume 24 ore:

155.59K

Relative Volume:

1.09

Capitalizzazione di mercato:

$5.70M

Reddito:

$3.19M

Utile/perdita netta:

$-10.42M

Rapporto P/E:

-0.1342

EPS:

-9.69

Flusso di cassa netto:

$-10.65M

1 W Prestazione:

-12.16%

1M Prestazione:

-7.14%

6M Prestazione:

-30.29%

1 anno Prestazione:

-69.91%

Intervallo 1D:

$1.24

$1.36

Intervallo di 1 settimana:

$1.20

$1.505

Portata 52W:

$1.00

$11.70

Intelligent Bio Solutions Inc Stock (INBS) Company Profile

Nome

Intelligent Bio Solutions Inc

Settore

Healthcare (1176)

Industria

Medical Devices (148)

Telefono

646-233-6971

Indirizzo

135 W 41ST ST,, NEW YORK

Dipendente

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

INBS's Discussions on Twitter

Confronta INBS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INBS Intelligent Bio Solutions Inc	1.30	5.70M	3.19M	-10.42M	-10.65M	-35.48
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Intelligent Bio Solutions Inc Borsa (INBS) Ultime notizie

Dec 18, 2024

Intelligent Bio Solutions Files FDA Application for 94% Accurate 10-Minute Drug Screening Breakthrough - StockTitan

Dec 18, 2024

Dec 15, 2024

Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com

Dec 15, 2024

Dec 04, 2024

Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET - Marketscreener.com

Dec 04, 2024

Intelligent Bio Solutions CEO to Discuss FDA Path & Clinical Results in Upcoming Fireside Chat - StockTitan

Dec 04, 2024

Dec 03, 2024

Intelligent Bio Solutions Releases Business Operations Presentation - TipRanks

Dec 03, 2024

Dec 01, 2024

Intelligent Bio Solutions completes fingerprint drug screening system study - MSN

Dec 01, 2024

Nov 26, 2024

Intelligent Bio Solutions Advances Fingerprint Drug Testing - TipRanks

Nov 26, 2024

Intelligent Bio : Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results Form 8 K - Marketscreener.com

Nov 26, 2024

Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results - The Manila Times

Nov 26, 2024

Nov 22, 2024

Intelligent Bio Solutions to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference - Marketscreener.com

Nov 22, 2024

Nov 21, 2024

Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - The Manila Times

Nov 21, 2024

Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference - Marketscreener.com

Nov 21, 2024

Intelligent Bio Solutions to Present at Noble Capital's 2024 Growth Conference | INBS Stock News - StockTitan

Nov 21, 2024

Intelligent Bio Solutions raises $250k via stock sales - Investing.com

Nov 21, 2024

Intelligent Bio Solutions raises $250k via stock sales By Investing.com - Investing.com Canada

Nov 21, 2024

INBS (Intelligent Bio Solutions) Peter Lynch Fair Value : $-443.54 (As of Nov. 21, 2024) - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

INBS (Intelligent Bio Solutions) Inventory Turnover : 0.69 (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024

Intelligent Bio Solutions Announces Study Results and Stock Sale - TipRanks

Nov 20, 2024

INBS (Intelligent Bio Solutions) Price-to-Free-Cash-Flow : N/A (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024

INBS (Intelligent Bio Solutions) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024

Intelligent Bio : INBS PK Study Results Video - Marketscreener.com

Nov 20, 2024

INBS (Intelligent Bio Solutions) EBITDA per Share : $-30.36 (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024

INBS (Intelligent Bio Solutions) Total Assets : $11.73 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024

INBS (Intelligent Bio Solutions) PensionAndRetirementBenefi - GuruFocus.com

Nov 20, 2024

INBS (Intelligent Bio Solutions) Price-to-Operating-Cash-Fl - GuruFocus.com

Nov 20, 2024

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study - MSN

Nov 20, 2024

Nov 15, 2024

Alyeska Investment Group's Strategic Acquisition of Intelligent Bio Solutions Inc Shares - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Intelligent gears up for FDA approval of fingerprint drug detection device - Yahoo Finance

Nov 14, 2024

INBS advances in drug detection with fingerprint technology By Investing.com - Investing.com Australia

Nov 14, 2024

Nov 13, 2024

Intelligent Bio Solutions Inc. Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com

Nov 13, 2024

INBS advances in drug detection with fingerprint technology - Investing.com

Nov 13, 2024

Intelligent Bio Solutions (INBS) Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - StreetInsider.com

Nov 13, 2024

Intelligent Bio Solutions Hits Major Breakthrough in Drug Detection Study, FDA Filing Next | INBS Stock News - StockTitan

Nov 13, 2024

Nov 10, 2024

Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024) - Yahoo Finance

Nov 10, 2024

Nov 08, 2024